MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 inter alia to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and half year ended 30th September 2021.
Please note that as per the Insider Trading Code of the Company the Trading Window for dealing in Companys shares has been closed for the Companys Designated Persons from 1st October 2021 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on 9th November 2021.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
